Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: keys to success and roads to failure. [electronic resource]
Producer: 20070202Description: 1578-94 p. digitalISSN:- 0885-3185
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- Animals
- Antiparkinson Agents -- adverse effects
- Basal Ganglia -- drug effects
- Clinical Trials, Phase II as Topic
- Drug Evaluation, Preclinical
- Drugs, Investigational -- therapeutic use
- Dyskinesia, Drug-Induced -- drug therapy
- Haplorhini
- Humans
- Treatment Failure
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.